Massachusetts Financial Services CO Phathom Pharmaceuticals, Inc. Transaction History
Massachusetts Financial Services CO
- $321 Billion
- Q1 2024
Shares
3 transactions
Others Institutions Holding PHAT
# of Institutions
123Shares Held
54.7MCall Options Held
34KPut Options Held
58.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$123 Million5.64% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$90.5 Million27.45% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$42.4 Million2.73% of portfolio
-
Invesco Ltd. Atlanta, GA3.16MShares$38.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.75MShares$33.3 Million0.0% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $475M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...